These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28641517)

  • 1. The Case for Cannabinoid CB1 Receptors as a Target for Bronchodilator Therapy for β-agonist Resistant Asthma.
    Ashton JC; Hancox RJ
    Curr Drug Targets; 2018; 19(11):1344-1349. PubMed ID: 28641517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance & resistance to β₂-agonist bronchodilators.
    Yim RP; Koumbourlis AC
    Paediatr Respir Rev; 2013 Sep; 14(3):195-8. PubMed ID: 23507501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β2-agonist therapy in lung disease.
    Cazzola M; Page CP; Rogliani P; Matera MG
    Am J Respir Crit Care Med; 2013 Apr; 187(7):690-6. PubMed ID: 23348973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we really need to keep redesigning β2-agonists for the management of asthma?
    Van Ly D; Oliver BG
    Curr Drug Deliv; 2015; 12(1):9-15. PubMed ID: 24909291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different patterns of exhaled nitric oxide response to β2-agonists in asthmatic patients according to the site of bronchodilation.
    Michils A; Malinovschi A; Haccuria A; Michiels S; Van Muylem A
    J Allergy Clin Immunol; 2016 Mar; 137(3):806-12. PubMed ID: 26688519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bedoradrine sulfate (MN-221), a novel, highly selective beta2-adrenergic receptor agonist for the treatment of asthma via intravenous infusion.
    Matsuda K; Makhay M; Johnson K; Iwaki Y
    J Asthma; 2012 Dec; 49(10):1071-8. PubMed ID: 23094708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advances in study of long β(2)-adrenoceptor agonist].
    Ge XY; Mo YM; Pan L; Cheng MS
    Yao Xue Xue Bao; 2016 Dec; 51(12):1838-44. PubMed ID: 29908535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Beta 2 adrenergic receptor (Thr164Ile) polymorphism with Salbutamol refractoriness in severe asthmatics from Indian population.
    Bandaru S; Tarigopula P; Akka J; Marri VK; Kattamuri RK; Nayarisseri A; Mangalarapu M; Vinukonda S; Mundluru HP; Sagurthi SR
    Gene; 2016 Oct; 592(1):15-22. PubMed ID: 27450915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosalbutamol in the treatment of asthma.
    Milgrom H
    Expert Opin Pharmacother; 2006 Aug; 7(12):1659-68. PubMed ID: 16872269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.
    Prenner BM
    Expert Opin Pharmacother; 2007 Dec; 8(17):3069-84. PubMed ID: 18001266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry-powder inhalers in acute asthma.
    Selroos O
    Ther Deliv; 2014 Jan; 5(1):69-81. PubMed ID: 24341818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological similarities and differences between beta2-agonists.
    Lötvall J
    Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors.
    Dutta S; Selvam B; Das A; Shukla D
    J Biol Chem; 2022 Apr; 298(4):101764. PubMed ID: 35227761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bedoradrine for treating asthma and chronic obstructive pulmonary disease.
    Antoniu S
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1149-56. PubMed ID: 24938936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olodaterol for the treatment of asthma.
    Cazzola M; Rinaldi B; Lucà G; Ora J
    Expert Opin Investig Drugs; 2016 Jul; 25(7):861-6. PubMed ID: 27170011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of beta2-agonist: key focus on signaling pathways.
    Bhatnagar P; Guleria R; Kukreti R
    Pharmacogenomics; 2006 Sep; 7(6):919-33. PubMed ID: 16981850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and novel bronchodilators in respiratory disease.
    Spina D
    Curr Opin Pulm Med; 2014 Jan; 20(1):73-86. PubMed ID: 24247039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy.
    Kume H; Fukunaga K; Oguma T
    Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.